Goldman Sachs’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-502,423
| Closed | -$774K | – | 7157 |
|
|
2021
Q4 | $774K | Buy |
502,423
+23,249
| +5% | +$38.4K | ﹤0.01% | 5060 |
|
|
2021
Q3 | $752K | Sell |
479,174
-33,804
| -7% | -$66.2K | ﹤0.01% | 4950 |
|
|
2021
Q2 | $1.35M | Buy |
512,978
+337,067
| +192% | +$628K | ﹤0.01% | 4538 |
|
|
2021
Q1 | $266K | Buy |
175,911
+45,003
| +34% | +$78K | ﹤0.01% | 5489 |
|
|
2020
Q4 | $170K | Sell |
130,908
-15,962
| -11% | -$18K | ﹤0.01% | 5145 |
|
|
2020
Q3 | $166K | Buy |
146,870
+10,708
| +8% | +$11.8K | ﹤0.01% | 4975 |
|
|
2020
Q2 | $113K | Sell |
136,162
-108,557
| -44% | -$80.6K | ﹤0.01% | 4964 |
|
|
2020
Q1 | $177K | Sell |
244,719
-22,936
| -9% | -$25.6K | ﹤0.01% | 4751 |
|
|
2019
Q4 | $356K | Buy |
267,655
+125,398
| +88% | +$175K | ﹤0.01% | 4681 |
|
|
2019
Q3 | $200K | Sell |
142,257
-312,552
| -69% | -$623K | ﹤0.01% | 4826 |
|
|
2019
Q2 | $1.47M | Buy |
454,809
+253,757
| +126% | +$874K | ﹤0.01% | 3738 |
|
|
2019
Q1 | $753K | Sell |
201,052
-31,892
| -14% | -$101K | ﹤0.01% | 4215 |
|
|
2018
Q4 | $505K | Buy |
232,944
+21,623
| +10% | +$53.6K | ﹤0.01% | 4356 |
|
|
2018
Q3 | $571K | Buy |
211,321
+163,482
| +342% | +$578K | ﹤0.01% | 4358 |
|
|
2018
Q2 | $203K | Buy |
47,839
+36,967
| +340% | +$139K | ﹤0.01% | 4987 |
|
|
2018
Q1 | $40K | Buy |
+10,872
| New | +$40.3K | ﹤0.01% | 5538 |
|
|
2017
Q1 | – | Sell |
-17,233
| Closed | -$85K | – | 7092 |
|
|
2016
Q4 | $85K | Sell |
17,233
-5,970
| -26% | -$27.1K | ﹤0.01% | 6214 |
|
|
2016
Q3 | $97K | Buy |
23,203
+5,145
| +28% | +$21K | ﹤0.01% | 6240 |
|
|
2016
Q2 | $72K | Sell |
18,058
-35,749
| -66% | -$140K | ﹤0.01% | 6279 |
|
|
2016
Q1 | $179K | Buy |
+53,807
| New | +$177K | ﹤0.01% | 5706 |
|
|
2015
Q4 | – | Sell |
-176,964
| Closed | -$743K | – | 7440 |
|
|
2015
Q3 | $743K | Buy |
176,964
+137,768
| +351% | +$869K | ﹤0.01% | 4760 |
|
|
2015
Q2 | $319K | Sell |
39,196
-5,608
| -13% | -$46.7K | ﹤0.01% | 5676 |
|
|
2015
Q1 | $348K | Buy |
44,804
+33,306
| +290% | +$285K | ﹤0.01% | 5502 |
|
|
2014
Q4 | $135K | Buy |
11,498
+446
| +4% | +$5.32K | ﹤0.01% | 6428 |
|
|
2014
Q3 | $143K | Sell |
11,052
-5,551
| -33% | -$73.2K | ﹤0.01% | 6403 |
|
|
2014
Q2 | $252K | Sell |
16,603
-5,129
| -24% | -$83.4K | ﹤0.01% | 6019 |
|
|
2014
Q1 | $461K | Buy |
+21,732
| New | +$630K | ﹤0.01% | 5358 |
|
Goldman Sachs's CSLT Position: Q1 2022 in Review
Goldman Sachs sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 502,423 shares — an estimated $774K sold.
Goldman Sachs first reported a position in CSLT in Q1 2014 and held it in 27 quarters. The position peaked at $1.47M in Q2 2019. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.
- Goldman Sachs reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
- Goldman Sachs sold 502,423 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $774K.
- Goldman Sachs first reported a position in CASTLIGHT HEALTH, INC. in Q1 2014 and held it in 27 quarters.
- Goldman Sachs's CASTLIGHT HEALTH, INC. position peaked at $1.47M in Q2 2019.
- 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.
Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.